After at least eight auditions, "Jeopardy!" superfan Harvey Silikovitz learned he was chosen to compete on the show. What he ...

In the future, therapies that focus on gut health—whether through diet, medication, or nerve stimulation—could be used to ...

The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

One of the world’s leading Parkinson’s disease scientists has warned of a potential pandemic of the neurological condition if research doesn’t “step up” to address the looming crisis.

The joint venture with generative AI firm Hologen hands MeiraGTx $200 million up front as well as other financial perks — a ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

Meiragtx's AAV-GAD program for Parkinson's disease is phase 3 ready, with positive data from a randomized, sham-controlled ...

The prevalence of Parkinson disease was projected to be 267 cases per 100,000 in 2050, representing a 76% increase from 2021. (HealthDay News) — The prevalence of Parkinson disease is projected to ...

Speaking to Coffee Friend this week, the foodie professional alleged that, when consumed regularly in its purest form, the ...

Researchers say structure reveals many new ways to change PINK1, essentially switching it on, which will be "life-changing" for people with Parkinson’s disease.

Researchers at the WEHI Parkinson’s Disease Research Centre have made a huge leap forward in the fight against Parkinson’s ...